About
Research Library
Company Pages
Allergy Therapeutics
Futura Medical
HUTCHMED (Hutchison China MediTech)
MaxCyte
Mereo BioPharma
Nexstim
Redx Pharma
Scancell
Contact
More Company News
Allergy Therapeutics
Interim H121 results
03 Mar 2021
Read More
Allergy Therapeutics
H121 trading update and notice of results
13 Jan 2021
Read More
Allergy Therapeutics
Initiation of peanut allergy biomarker study
05 Jan 2021
Read More
Allergy Therapeutics
Initiation of Grass MATA MPL exploratory study
26 Oct 2020
Read More
Allergy Therapeutics
FY20 preliminary results
23 Sep 2020
Read More
Allergy Therapeutics
Allergy Therapeutics secures VLP technology platform
03 Sep 2020
Read More
Allergy Therapeutics
FY20 trading update
15 Jul 2020
Read More
Allergy Therapeutics
Invalidation of Birch MATA MPL Phase III results
09 Jul 2020
Read More
Allergy Therapeutics
Trading update
24 Jun 2020
Read More
Allergy Therapeutics
EAACI review of adjuvants and formulations
22 Apr 2020
Read More
1
2
Return to Allergy Therapeutics
© 2019-21 Trinity Delta. All rights reserved. Trinity Delta is regulated by the Financial Conduct Authority (Reference number: 725161).
About
Research Library
Company Pages
▼
Allergy Therapeutics
Futura Medical
HUTCHMED (Hutchison China MediTech)
MaxCyte
Mereo BioPharma
Nexstim
Redx Pharma
Scancell
Contact